PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
NCT ID: NCT01659970
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
152 participants
OBSERVATIONAL
2012-06-30
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically or cytologically confirmed advanced (Stage IIIB) or metastatic (Stage IV) squamous non-small cell lung cancer after failure of first-line platinum-based chemotherapy
* Patients for whom the treating physician has decided to initiate treatment with Tarceva
Exclusion Criteria
* Current participation in a clinical trial evaluating an anticancer treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abbeville, , France
Agen, , France
Aix-en-Provence, , France
Aix-en-Provence, , France
Amiens, , France
Angers, , France
Antibes, , France
Armentières, , France
Aulnay-sous-Bois, , France
Bar-le-Duc, , France
Bayonne, , France
Beuvry, , France
Bordeaux, , France
Boulogne-Billancourt, , France
Bourg-en-Bresse, , France
Brive-la-Gaillarde, , France
Bron, , France
Bry-sur-Marne, , France
Carcassonne, , France
Castres, , France
Chalon-sur-Saône, , France
Chambéry, , France
Charleville-Mézières, , France
Chaumont, , France
Chauny, , France
Clamart, , France
Clermont-Ferrand, , France
Colmar, , France
Compiègne, , France
Créteil, , France
Dijon, , France
Dijon, , France
Draguignan, , France
Dunkirk, , France
Ermont, , France
Épernay, , France
Férolles-Attilly, , France
Forbach, , France
Gap, , France
Gleizé, , France
Gonesse, , France
La Rochelle, , France
La Source, , France
La Tronche, , France
Lagny-sur-Marne, , France
Le Mans, , France
Le Mans, , France
Le Puy-en-Velay, , France
Lille, , France
Lille, , France
Lille, , France
Limoges, , France
Lisieux, , France
Longjumeau, , France
Lorient, , France
Lyon, , France
Lyon, , France
Manosque, , France
Mantes-la-Jolie, , France
Mareuil-lès-Meaux, , France
Marseille, , France
Meaux, , France
Metz, , France
Metz-Tessy, , France
Mont-de-Marsan, , France
Montpellier, , France
Nancy, , France
Nantes, , France
Narbonne, , France
Neuilly-sur-Seine, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Perpignan, , France
Perpignan, , France
Pierre-Bénite, , France
Poitiers, , France
Pontoise, , France
Quimper, , France
Rambouillet, , France
Reims, , France
Reims, , France
Rennes, , France
Rouen, , France
Rouen, , France
Saint-Dié, , France
Saint-Dizier, , France
Saint-Jean, , France
Saint-Laurent-du-Var, , France
Saint-Omer, , France
Saint-Priest-en-Jarez, , France
Saint-Priest-en-Jarez, , France
Saint-Quentin, , France
Saintes, , France
Strasbourg, , France
Strasbourg, , France
Strasbourg, , France
Strasbourg, , France
Thionville, , France
Thonon-les-Bains, , France
Toulon, , France
Toulon, , France
Toulouse, , France
Tours, , France
Valence, , France
Vandœuvre-lès-Nancy, , France
Vannes, , France
Verdun, , France
Vénissieux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28195
Identifier Type: -
Identifier Source: org_study_id